Cognitive and behavioral effects of epilepsy treatment

Epilepsia

Volumn 42, Issue SUPPL. 6, 2001, Pages 24-32

  Loring, D W ^a   Meador, K J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Anticonvulsants; Antiepileptic drugs; Cognitive effects; Epilepsy; Epilepsy treatment

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

AGE; ARTICLE; BEHAVIOR DISORDER; CLINICAL TRIAL; COGNITIVE DEFECT; DOSE RESPONSE; DRUG EFFECT; EPILEPSY; HUMAN; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SOMNOLENCE;

EID: 0035217920     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.42.s8.8.x     Document Type: Article

References (99)

1. Progressive hippocampal atrophy in chronic intractable temporal lobe epilepsy
2. Neuropsychological effects of carbamazepine and phenytoin: A reanalysis
3. Psychotropic effects of carbamazepine in epilepsy: A double-blind comparison with phenytoin
4. Comparative cognitive effects of anticonvulsants
5. Behavioral characteristics of epilepsy patients compared with normal controls
6. Effect of valproate on cognitive functioning: Comparison with carbamazepine: The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group
7. Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients
8. Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: A comparative study
9. Comparing the cognitive effects of phenytoin and carbamazepine in long-term monotherapy: A twoyear follow-up
10. Neuropsychological abilities before and after 5 years of stable antiepileptic drug therapy
11. Memory and attention in newly diagnosed epileptic seizure disorder
12. Complex partial and secondarily generalized seizure patients: Cognitive functioning prior to treatment with antiepileptic medication: VA Epilepsy Cooperative Study 264 Group
13. Comparative cognitive effect of carbamazepine and phenytoin in healthy adults
14. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults
15. Effect of gabapentin (Neurontin) on mood and well-being in patients with epilepsy
16. Cognitive abilities and adjustment with gabapentin: Results of a multisite study
17. A beneficial effect on mood in partial epilepsy patients treated with gabapentin
18. Behavioral side effects of gabapentin in children
19. Gabapentin toxicity in children manifesting as behavioral changes
20. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry
21. Gabapentin and cognition: A double blind, dose ranging, placebo controlled study in refractory epilepsy
22. Differential cognitive effects of carbamazepine and gabapentin
23. Lamotrigine (BW430C), a potential anticonvulsant: Effects on the central nervous system in comparison with phenytoin and diazepam
24. Carbamazepine and lamotrigine in healthy volunteers: Relevance to early tolerance and clinical trial dosage
25. Outcomes of add-on treatment with lamotrigine in partial epilepsy
26. Differential cognitive and behavioral effects of carbamazepine and lamotrigine
27. The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability
28. Behavioral and cognitive effects of lamotrigine
29. Intractable epilepsy in children: The efficacy of lamotrigine treatment, including non-seizure-related benefits
30. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments
31. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin
32. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: One year follow-up
33. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers
34. Neuropsychological effects of tiagabine, a potential new antiepileptic drug
35. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy
36. Assessing cognitive effects of a new AED without bias of practice effects
37. Effects of topiramate on cognitive function
38. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults
39. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures
40. Topiramate (TPM) or valproate (VPA) added to carbamazepine (CBA) in adults with epilepsy: Effects on subjective and objective measures of cognitive function
41. Psychotic and severe behavioural reactions with vigabatrin: A review
42. Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy
43. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy
44. Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy
45. Effects of vigabatrin on partial seizures and cognitive function
46. Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor
47. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy: A randomized, controlled study
48. Zonisamide (CI-912) and cognition: Results from preliminary study
49. Impact of valproate and phenytoin on cognitive function in elderly patients: Results of a single-blind randomized comparative study
50. Cognitive effects of anticonvulsant monotherapy in elderly patients: A placebocontrolled study
51. Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults
52. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy: The UK Lamotrigine Elderly Study Group
53. Psychologic and behavioral effects of antiepileptic drugs in children: A double-blind comparison between phenobarbital and valproic acid
54. Phenobarbital for febrile seizures: Effects on intelligence and on seizure recurrence
55. Side effects of phenobarbital in toddlers; behavioral and cognitive aspects
56. Withdrawal of antiepileptic medication in children: Effects on cognitive function: The Multicenter Holmfrid study
57. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate
58. One drug for childhood grand mal: Medical audit for three-year remissions
59. Withdrawal of antiepileptic medication in children: Correlation of cognitive function and plasma concentration: The multicentre "Holmfrid" study
60. Cognitive effects of epilepsy and of antiepileptic medications
61. Additional educational needs in children born to mothers with epilepsy
62. Anterior temporal lobectomy for the control of partial complex seizures: Information for counseling patients
63. Neuropsychological effect of temporal lobe resection in preadolescent children with epilepsy
64. Pathological status of the mesial temporal lobe predicts memory outcome from left anterior temporal lobectomy
65. MRI hippocampal volumes and memory function before and after temporal lobectomy
66. Neuropsychological outcome following anterior temporal lobectomy in patients with and without the syndrome of mesial temporal lobe epilepsy
67. Amnesia after unilateral temporal lobectomy: A case report
68. Crossed aphasia in a patient with complex partial seizures: Evidence from intracarotid amobarbital testing, functional cortical mapping, and neuropsychological assessment
69. Hippocampal contribution to verbal recent memory following dominant-hemisphere temporal lobectomy
70. Neurocognitive efficiency following left temporal lobectomy: Standard versus limited resection
71. Prediction of cognitive change as a function of preoperative ability status among temporal lobectomy patients seen at 6-month follow-up
72. Selective memory improvement and impairment in temporal lobectomy for epilepsy
73. Psychological status related to surgical control of temporal lobe seizures
74. Effects of temporal lobectomy on generative fluency and other language functions
75. Language before and after temporal lobectomy: Specificity of acute changes and relation to early risk factors
76. Left anterior lobectomy and category-specific naming
77. Differences between nouns and verbs after anterior temporal lobectomy
78. Effects of anterior temporal lobectomy on language function: A controlled study
79. Language function following anterior temporal lobectomy
80. Relation of cortical language distribution and cognitive function in surgical epilepsy patients
81. Multiple subpial transections in the language cortex
82. Occupational outcome after temporal lobectomy for refractory epilepsy
83. Factors associated with work outcome after anterior temporal lobectomy for intractable epilepsy
84. Cognition and behavior after temporal lobectomy in pediatric patients with intractable epilepsy
85. Temporal lobectomy in children: Cognitive outcome
86. Multiple subpial transection: A new approach to the surgical treatment of focal epilepsy
87. Multiple subpial transections for partial seizures in sensorimotor cortex
88. Multiple subpial transection for control of epileptic seizures: Effectiveness and safety
89. Multiple subpial transections in language cortex: Effects on language function
90. Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy
91. Long-term multicenter experience with vagus nerve stimulation for intractable partial seizures: Results of the XE5 trial
92. Long-term results of vagus nerve stimulation in refractory epilepsy
93. Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study
94. Vagus nerve stimulation for medication-resistant generalized epilepsy: E04 VNS Study Group
95. Vagus nerve stimulation for medically refractory epilepsy; efficacy and cost-benefit analysis
96. Vagus nerve stimulation for epilepsy: A review
97. Posttraining electrical stimulation of vagal afferents with concomitant vagal efferent inactivation enhances memory storage processes in the rat
98. Enhanced recognition memory following vagus nerve stimulation in human subjects
99. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation